Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma. Issue 8 (September 2016)
- Record Type:
- Journal Article
- Title:
- Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma. Issue 8 (September 2016)
- Main Title:
- Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
- Authors:
- Dotan, Efrat
Alpaugh, R. Katherine
Ruth, Karen
Negin, Benjamin P.
Denlinger, Crystal S.
Hall, Michael J.
Astsaturov, Igor
McAleer, Cecilia
Fittipaldi, Patricia
Thrash-Bingham, Catherine
Meropol, Neal J.
Cohen, Steven J. - Abstract:
- Abstract : Objectives: Development of targeted therapies for pancreatic cancer could be enhanced by a reliable method for noninvasive tumor cell assessment. In this pilot study, we isolated and phenotypically characterized circulating tumor cells (CTCs) from patients with metastatic pancreatic cancer and explored their relationship to clinical outcome. Methods: Peripheral blood from 50 patients was collected at treatment initiation and first disease evaluation for CTC enumeration and phenotyping by CellSearch® system. Expression of human mucin 1 (MUC-1) was performed. Results: Forty-eight and 37 patients had evaluable samples at baseline and first disease evaluation, respectively. The cohort was 62% male, with a median age of 63 years. At least 1 CTC per 7.5 mL was detected in 23 patients (48%) pretreatment and 11 patients (30%) at first disease evaluation. No difference was seen in overall survival between patients with 1 or more CTCs versus no CTC at baseline ( P = 0.14). Patients with MUC-1 expressing CTC (n = 10) had shorter median overall survival compared with those with MUC-1 negative CTC (n = 13; 2.7 vs 9.6 m; P = 0.044). Conclusions: Circulating tumor cell enumeration and phenotypic characterization from metastatic pancreatic cancer patients are feasible. No correlation was found between CTC isolation and survival. However, the presence of MUC-1 expressing CTC demonstrated a trend toward inferior survival.
- Is Part Of:
- Pancreas. Volume 45:Issue 8(2016)
- Journal:
- Pancreas
- Issue:
- Volume 45:Issue 8(2016)
- Issue Display:
- Volume 45, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 45
- Issue:
- 8
- Issue Sort Value:
- 2016-0045-0008-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-09
- Subjects:
- pancreatic cancer -- circulating tumor cells -- MUC-1 -- mucin 1
Pancreas -- Diseases -- Periodicals
Pancreas -- Periodicals
Neuroendocrine tumors -- Periodicals
616.37005 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00006676-000000000-00000 ↗
http://www.pancreasjournal.com ↗
http://journals.lww.com/pancreasjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPA.0000000000000619 ↗
- Languages:
- English
- ISSNs:
- 0885-3177
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6357.351500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2745.xml